Here are the S-3 shelf registrations from Cassava Sciences, Inc. (SAVA) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow SAVA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SAVA filings page.
Cassava Sciences filed an S-3 shelf registration for the primary offering of up to $200,000,000 in various securities, including common stock, preferred stock, depositary shares, warrants, rights, debt securities, and units. The filing also includes an at-the-market prospectus supplement for up to $50,000,000 of common stock under a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co.
Sales under the ATM may be made from time to time in transactions deemed an “at the market offering” pursuant to Rule 415. Cassava will pay Cantor up to 3.0% of the aggregate sales price as commissions. Cassava’s common stock trades on Nasdaq as “SAVA”; the closing price was $3.11 per share on November 11, 2025. Shares outstanding were 48,307,896 as of November 10, 2025.
Unless otherwise stated in a supplement, proceeds are for general corporate purposes and working capital, and the ATM amount is included within the overall $200,000,000 shelf capacity.